p-ThuLEP and Open Prostatectomy Show Comparable Early BPH Outcomes

Early outcomes for patients treated with p-ThuLEP (prostate thulium laser enucleation of the prostate) are comparable to those who undergo open prostatectomy for benign prostatic hyperplasia (BPH), according to a study reported by Medical Xpress on June 30, 2026. The findings suggest that the minimally invasive laser procedure provides similar relief of urinary symptoms and effectiveness in removing prostate tissue as the traditional open surgery.

Benign prostatic hyperplasia is a noncancerous enlargement of the prostate gland that can obstruct urine flow and lead to significant bladder dysfunction. While open prostatectomy has long served as a standard for large prostates, the study indicates that p-ThuLEP offers a viable alternative with similar early clinical results.

How does p-ThuLEP compare to open prostatectomy?

The research compared the efficacy and safety of p-ThuLEP against open prostatectomy, focusing on early postoperative recovery and symptom improvement. According to the report from Medical Xpress, both procedures resulted in similar improvements in urinary flow rates and the reduction of prostate volume.

Open prostatectomy requires a surgical incision to physically remove the obstructing part of the prostate. In contrast, p-ThuLEP uses a thulium laser to enucleate, or peel away, the obstructive tissue through the urethra, avoiding the need for an external incision.

The study found that the early functional outcomes—specifically the ability of the patient to void urine effectively and the resolution of BPH symptoms—did not differ significantly between the two groups.

What are the clinical advantages of thulium laser enucleation?

Laser-based treatments generally aim to reduce the complications associated with invasive surgery. According to the data cited by Medical Xpress, p-ThuLEP is characterized as a minimally invasive approach.

The use of thulium lasers in prostate surgery is designed to provide precise tissue removal while minimizing blood loss. This is a contrast to open surgery, which typically involves higher risks of hemorrhage and longer hospital stays due to the nature of the abdominal incision.

By achieving comparable outcomes to the open approach, the p-ThuLEP procedure allows surgeons to treat larger prostates—which were previously reserved for open surgery—using a technique that potentially reduces recovery time and surgical trauma.

Why do these findings matter for BPH treatment?

The ability to achieve “comparable” outcomes means that the gold standard for large-volume prostate removal is no longer exclusively tied to open surgery. This shift allows for a broader application of laser technology in urology.

Patients with BPH often face a choice between medication, which manages symptoms, and surgery, which removes the obstruction. The verification that p-ThuLEP matches the effectiveness of open prostatectomy provides a clinical basis for recommending laser enucleation for patients who seek the efficacy of surgery without the morbidity of a large open wound.

Medical professionals evaluate these procedures based on the International Prostate Symptom Score (IPSS) and maximum urinary flow rates. The reported comparability suggests that the thulium laser is capable of removing the same amount of obstructive tissue as a surgeon using a scalpel in an open procedure.

What remains uncertain about p-ThuLEP?

While the early outcomes are comparable, the study focuses on the initial postoperative period. Long-term data is necessary to determine if the durability of the p-ThuLEP results matches that of open prostatectomy over several years.

Additionally, the level of surgical expertise required to perform p-ThuLEP is higher than that of some traditional methods. The precision of the thulium laser requires specific training to ensure the prostate is fully enucleated without damaging surrounding tissues.

Future research will likely focus on comparing the long-term re-operation rates and the late-stage recurrence of BPH symptoms between these two surgical modalities.